Altamira Therapeutics Ltd. Other Current Receivables
Altamira Therapeutics Ltd. (CYTOF) had Other Current Receivables of $213.39 thousand as of 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes › Receivables
ifrs-full:OtherCurrentReceivables · last filed 2025-08-29
- 2023-12-31: Other Current Receivables 74.82K CHF.
- 2023-06-30: Other Current Receivables 756.23K CHF.
- 2022-12-31: Other Current Receivables 755.99K CHF.
- 2021-12-31: Other Current Receivables 671.34K CHF; Other Current Receivables as first filed 917.83K CHF.
CHF
| Period end | Other Current Receivables | Other Current Receivables as first filed |
|---|---|---|
| 2023-12-31 | 74.82K CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | 756.23K CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | 755.99K CHF 20-F/A · filed 2024-04-22 | |
| 2021-12-31 | 671.34K CHF 20-F · filed 2023-05-16 | 917.83K CHF 20-F · filed 2022-04-12 |
| 2020-12-31 | 80.86K CHF 20-F · filed 2022-04-12 | |
| 2019-12-31 | 335.30K CHF 20-F · filed 2021-03-31 | |
| 2018-12-31 | 320.37K CHF 20-F · filed 2020-04-16 | |
| 2017-12-31 | 241.28K CHF 20-F · filed 2019-03-14 | |
| 2016-12-31 | 296.53K CHF 20-F · filed 2018-03-22 |
USD
| Period end | Other Current Receivables |
|---|---|
| 2025-06-30 | $213.39K 6-K · filed 2025-08-29 |
| 2024-12-31 | $351.33K 6-K · filed 2025-08-29 |
| 2024-06-30 | $121.31K 6-K · filed 2024-09-24 |
| 2023-12-31 | $88.92K 20-F · filed 2025-04-30 |
| 2023-01-01 | $817.20K 20-F · filed 2025-04-30 |